Skip to content

Detection of the expression level of PGF2a in tears of dry eye patients and normal people

Study on the correlation between prostaglandin F2a and the severity of dry eye

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200061955
Enrollment
Unknown
Registered
2022-07-13
Start date
2022-08-01
Completion date
Unknown
Last updated
2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dry eye

Interventions

Group 1:
Group 2:

Sponsors

Eye Institute of Xiamen University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Voluntarily participate in this clinical research and sign the informed consent; 2. Aged 18-70 years old; 3. The dry eye patient group must also meet the following criteria: clinical symptoms and signs of dry eye, and clinical examination results in line with the diagnostic criteria of the Chinese Dry Eye Expert Consensus (2020) (as follows): (1) Chinese dry eye questionnaire score >= 7 points, and the patient's BUT = 7 points, and when the patient's 5 = 5 points) can be diagnosed; 4. Normal healthy subjects group: no dry eye symptoms, BUT > 10 s, Schirmer I test greater than 10 mm/5 min.

Exclusion criteria

Exclusion criteria: 1. Eye allergy, infection, severe blepharitis and eye irritation unrelated to dry eye; 2. Punctal embolism; 3. Other topical or systemic drugs other than artificial tears are being used; 4. Use artificial tears 2 hours before the examination; 5. Have a history of wearing contact lenses in the past 1 month; 6. Those who have had eye surgery or eye trauma in the past 6 months; 7. Patients with severe primary diseases such as cardiovascular, liver, kidney and hematopoietic systems and systemic immune diseases; 8. Hormone replacement therapy for pregnant and lactating women, menopausal women; 9. Those who have participated in other clinical trials in the past 1 month.

Design outcomes

Primary

MeasureTime frame
Prostaglandin F2a;

Countries

China

Contacts

Public ContactZuguo Liu

Eye Institute of Xiamen University

zuguoliu@xmu.edu.cn+86 18959289999

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026